FDA Orange Book

Is there a generic for Nereus?

Nereus contains tradipitant. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.

Source: FDA Orange Book data file dated 2026-10-09. Publisher page

No. The Orange Book lists no active FDA-approved generic (ANDA) for Nereus (tradipitant). The Orange Book shows its last listed patent expires August 9, 2036 and its last listed exclusivity ends December 30, 2030.

Run it in Rivvi

Map Nereus and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Nereus products in the Orange Book

Nereus products and approved generics
Form and routeStrengthBrand statusBrand TEActive genericsGeneric TE codes
capsule, oral85MGMarketed (Rx)None0None

NDA 220152, held by VANDA PHARMACEUTICALS INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Nereus patents

Patents listed for Nereus
PatentExpiresCoversUse codeNDA
11324735March 4, 2036Method of useU-4396220152
10821099March 4, 2036Method of useU-4396220152
10772880March 4, 2036Method of useU-4396220152
12318375August 9, 2036Method of useU-4396220152

Nereus exclusivity

Exclusivity listed for Nereus
CodeMeaningExpiresNDA
NCENew chemical entityDecember 30, 2030220152

Nereus NDC codes

Questions

Is there a generic for Nereus?

No. The Orange Book lists no active FDA-approved generic (ANDA) for Nereus (tradipitant). The Orange Book shows its last listed patent expires August 9, 2036 and its last listed exclusivity ends December 30, 2030.

What is the generic name for Nereus?

The active ingredient in Nereus is tradipitant, per the FDA Orange Book.

When does the Nereus patent expire?

The last patent listed for Nereus in the Orange Book expires August 9, 2036. A listed patent expiry date is not a generic launch date.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.

More on Nereus and Tradipitant

Try it on your own data today.

Free to start. Most teams are using it the same day.